Skip to content

MassBio

Massachusetts Biotechnology Council

Open search form
  • Sign In/Create Account
  • Pay Company Dues
  • Become a Member
  • Resources
    • 2022 Massachusetts Biopharma Funding Report
    • 2022 Industry Snapshot
    • 2022 MA Life Sciences Workforce Analysis Report
    • 2021 State of Diversity, Equity, & Inclusion Report
    • Economic Development
    • Value of Health
    • Biopharma Startup Toolkit
    • Career Center
    • MassBioEd
  • Events
    • Events Calendar
    • Overview of Events
    • Get Involved
  • Membership
    • Member Directory
    • Benefits of Membership
    • Savings and Rewards
    • Member News
    • Become a Member
    • Member Rates
    • Pay Company Dues
  • Savings & Rewards
    • MassBioEdge
  • Conference Center
    • MassBioHub
  • Programs
    • Workforce Training Center at Southline Boston
    • State of Possible 2025 Report
    • Diversity, Equity, and Inclusion
    • Policy & Advocacy
    • Partnering Week 2022
    • Partnering Opportunities
    • MassBioDrive
    • Digital Health
    • BioReady Communities
  • About Us
    • About Us
    • News & Thought Leadership
    • Sponsorship Opportunities
    • Staff
    • Board of Directors
    • FAQs
    • Contact Us
  • Sign In/Create Account
  • Pay Company Dues
  • Become a Member
Open search form

Member Directory

Click to Open Main Menu

UCB

Life Sciences | Drug Development
Bedford, MA Website @UCBUSA

Overview

Massachusetts is the home to our growing UCB US Research and Development (R&D) hub. We have more than 125 UCB employees across our facilities in Bedford and Cambridge, in addition to our field-based employees across the state.

We believe ground-breaking research best flourishes in innovative ecosystems. This is why UCB’s presence in Massachusetts is critical for our work to further scientific understanding and uncover new discoveries. We’re exploring novel areas of research, testing hypotheses on what drives disease progression and can modify disease and researching new ways to better connect science to the needs of patients.

At our 94,000 square feet of lab and office facilities in Cambridge and Bedford, our scientists are working on new platforms and projects we aim that one day will lead to cures. Building on UCB’s existing global capabilities, our team is focused on developing capabilities in areas including targeted protein degradation, protein biochemistry, and structural biology and leveraging a proprietary peptide chemistry platform as ways to discover new medicines for treating patient populations with severe neurodegenerative and immunological diseases, including those that are rare. More info on UCB in rare disease.

UCB’s External Innovation and Ventures teams also have a presence in Cambridge to ensure we are keeping connected with latest opportunities and exploring new areas for partnership, collaboration, and investment. UCB Ventures is actively investing in emerging biotech.

Company News

News

Inspiring a Culture of Diversity, Equity, & Inclusion at UCB in Massachusetts

Jul 14, 2022

Posted by UCB

News

Finding Success as a Scientist: Women and Diversity in Science with Cierra Spencer

Oct 26, 2021

Posted by UCB

See all Members

Massachusetts Biotechnology Council

700 Technology Square, 5th Floor
Cambridge, MA 02139
617.674.5100

  • Contact
  • Privacy Policy
  • Fulfillment Policy
  • © 2023 All Rights Reserved